Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation

• Brice Mouttet,
• Luciana Vinti,
• Philip Ancliff,
• Nicole Bodmer,
• Benoît Brethon,
• Gunnar Cario,
• Christiane Chen-Santel,
• Sarah Elitzur,
• Volkan Hazar,
• Joachim Kunz,
• Anja Möricke,
• Jerry Stein,
• Ajay Vora,
• Yöntem Yaman,
• Martin Schrappe,
• Sema Anak,
• André Baruche,
• Franco Locatelli,
• Arend von Stackelberg,
• Martin Stanulla,
• Jean-Pierre Bourquin

Affiliations

Brice Mouttet

Pediatric Oncology, University Children’s Hospital Zurich, Switzerland

Luciana Vinti

Department of Pediatric Haemato-Oncology, IRCCS Ospedale Bambino Gesù, Sapienza University of Rome, Italy

Philip Ancliff

Haematology and Oncology Department, Great Ormond Street Hospital, London, UK

Nicole Bodmer

Pediatric Oncology, University Children’s Hospital Zurich, Switzerland

Benoît Brethon

Department of Pediatric Hematology, Hôpital Robert Debré, Assistance Publique – Hôpitaux de Paris, France

Gunnar Cario

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Christiane Chen-Santel

Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany

Sarah Elitzur

Pediatric Hematology-Oncology, Schneider Children’s Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel

Volkan Hazar

Department of Pediatric Hematology, Medipol University Hospital, Istanbul, Turkey

Joachim Kunz

Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany

Anja Möricke

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Jerry Stein

Bone Marrow Transplant Unit, Schneider Children’s Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel

Ajay Vora

Haematology and Oncology Department, Great Ormond Street Hospital, London, UK

Yöntem Yaman

Department of Pediatric Hematology, Medipol University Hospital, Istanbul, Turkey

Martin Schrappe

Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany;Pediatrics, Christian Albrechts University Kiel, University Medical Center, Kiel, Germany

Sema Anak

Department of Pediatric Hematology, Medipol University Hospital, Istanbul, Turkey

André Baruche

Pediatric Oncology, University Children’s Hospital Zurich, Switzerland;Department of Pediatric Hematology, Hôpital Robert Debré, Assistance Publique – Hôpitaux de Paris, France

Franco Locatelli

Department of Pediatric Haemato-Oncology, IRCCS Ospedale Bambino Gesù, Sapienza University of Rome, Italy

Arend von Stackelberg

Department of Pediatric Oncology/Hematology, Charité Universitätsmedizin, Berlin, Germany

Martin Stanulla

Pediatric Hematology and Oncology, Hannover Medical School, Germany

Jean-Pierre Bourquin

Pediatric Oncology, University Children’s Hospital Zurich, Switzerland